Literature DB >> 6211490

Antibodies in the sera of patients with systemic lupus erythematosus that block the binding of monoclonal anti-Ia to Ia-positive targets also inhibit the autologous mixed lymphocyte response.

K Okudaira, R P Searles, J S Goodwin, R C Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6211490

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  10 in total

Review 1.  Immunopathogenesis of the neuropsychiatric manifestations of systemic lupus erythematosus.

Authors:  H G Bluestein; K D Pischel; V L Woods
Journal:  Springer Semin Immunopathol       Date:  1986

2.  New lymphokines produced by SLE sera stimulated lymphocytes: the PNAF (polymorphonuclear activating factors).

Authors:  M T Labro-Bryskier; C Babin-Chevaye; J Hakim
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

3.  Lymphocyte-reactive antibodies in acquired immune deficiency syndrome.

Authors:  R C Williams; H Masur; T J Spira
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

4.  Differences in the kinetics of the autologous mixed lymphocyte reaction between the various connective tissue diseases.

Authors:  A Laffón; J Alcocer-Varela; D Alarcón-Segovia
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

5.  Characterization of a factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.

Authors:  M A Kerr; Y M Hussein; R C Potts; J S Beck; M M Sheriff
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

6.  Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons.

Authors:  M B Sztein; P S Steeg; H M Johnson; J J Oppenheim
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

7.  Complexes of soluble HLA antigens and anti-HLA autoantibodies in human sera: possible role in maintenance of self-tolerance.

Authors:  D W King; E Reed; N Suciu-Foca
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

8.  Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus.

Authors:  A Yamada; J B Winfield
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

9.  Autoimmunity to a 28-30 kD cell membrane DNA binding protein: occurrence in selected sera from patients with SLE and mixed connective tissue disease (MCTD).

Authors:  R M Bennett; K A Cornell; M J Merritt; A C Bakke; P H Hsu; S H Hefeneider
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

10.  Antibodies against major histocompatibility complex class II antigens directly inhibit the growth of T cells infected with Theileria parva without affecting their state of activation.

Authors:  M Eichhorn; T D Prospero; V T Heussler; D A Dobbelaere
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.